Mupirocin resistance in clinical isolates of Staphylococcus aureus

Infection Control and Hospital Epidemiology

Volumn 24, Issue 4, 2003, Pages 300-301

  Jones, Paula G ^a   Sura, Terri ^b   Harris, Michael ^b   Strother, Anne ^b  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BLOOD CULTURE; DRUG EFFICACY; ERADICATION THERAPY; MINIMUM INHIBITORY CONCENTRATION; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; HUMANS; INPATIENTS; MICROBIAL SENSITIVITY TESTS; MUPIROCIN; STAPHYLOCOCCUS AUREUS;

EID: 0038071579     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502204     Document Type: Article

References (10)

1. Kauffman CA, Terpenning MS, He X, et al. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term facility with the use of mupirocin ointment. Am J Med 1993;94:371-378.
2. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R, Pittet D. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999;43:1412-1416.
3. Morton TM, Johnston JL, Patterson J, Archer GL Characterization of a conjugative staphylococcal mupirocin resistance plasmid. Antimicrob Agents Chemother 1995;39:1272-1280.
4. Bradley SF, Ramsey MA, Morton TM, Kauffman CA. Mupirocin resistance: clinical and molecular epidemiology. Infect Control Hosp Epidemiol 1995;16:354-358.
5. Henkel T, Finlay J. Emergence of resistance during mupirocin treatment: is it a problem in clinical practice? J Chemother 1999;11:331-337.
6. Semret M, Miller MA. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains. Infect Control Hosp Epidemiol 2001;22:578-580.
7. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Wayne, PA. National Committee for Clinical Laboratory Standards; 1998. Document M100-S8.
8. Finlay JE, Miller LA, Poupard JA. Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob Agents Chemother 1997;41:1137-1139.
9. Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Falcon TG, Valdes F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002;39:337-341.
10. Annigeri R, Conly J, Vas S, et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001;21:554-559.